Skip to main content
. 2017 Oct 24;8(61):102888–102897. doi: 10.18632/oncotarget.21986

Figure 3. Schematic representation of the pathways affected in PB-DLBCL by mutations.

Figure 3

The most frequently mutated genes involved BCR and NFkB pathways and are more prevalent in non-GCB DLBCL. Stars: recurrently mutated genes in PB-DLBCL.